AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2010
Jun 1, 2010
32801_dirs_2010-06-01_8fabbf89-1137-406c-9c42-903b070d536f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2010-05-27
Reporting Person: Maynard Ryan D (EVP & CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-27 | Stock Option (Right to Buy) | $6.55 | A | 120000 | Acquired | 2020-05-27 | Common Stock (120000) | Direct |
Footnotes
F1: Vests monthly over one (1) year from March 26, 2010.
More from RIGEL PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19